GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huons Global Co Ltd (XKRX:084110) » Definitions » Gross Profit

Huons Global Co (XKRX:084110) Gross Profit : ₩427,475 Mil (TTM As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Huons Global Co Gross Profit?

Huons Global Co's gross profit for the three months ended in Mar. 2024 was ₩107,036 Mil. Huons Global Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₩427,475 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Huons Global Co's gross profit for the three months ended in Mar. 2024 was ₩107,036 Mil. Huons Global Co's Revenue for the three months ended in Mar. 2024 was ₩201,881 Mil. Therefore, Huons Global Co's Gross Margin % for the quarter that ended in Mar. 2024 was 53.02%.

Huons Global Co had a gross margin of 53.02% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Huons Global Co was 59.11%. The lowest was 43.16%. And the median was 55.15%.

Warning Sign:

Huons Global Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.3%.


Huons Global Co Gross Profit Historical Data

The historical data trend for Huons Global Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huons Global Co Gross Profit Chart

Huons Global Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 256,192.86 291,081.92 323,381.97 365,628.84 418,208.96

Huons Global Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97,769.32 110,194.80 105,950.02 104,294.82 107,035.63

Competitive Comparison of Huons Global Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Huons Global Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huons Global Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huons Global Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Huons Global Co's Gross Profit falls into.



Huons Global Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Huons Global Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=758379.661 - 340170.703
=418,209

Huons Global Co's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=201881.135 - 94845.502
=107,036

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩427,475 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Huons Global Co's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=107,036 / 201881.135
=53.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Huons Global Co  (XKRX:084110) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Huons Global Co had a gross margin of 53.02% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Huons Global Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Huons Global Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Huons Global Co (XKRX:084110) Business Description

Traded in Other Exchanges
N/A
Address
901, Pangyo Innovalley C, 621, Sampyeong-dong Bundang-gu, Gyeonggi-do, KOR, 153-788
Huons Global Co Ltd is active in the healthcare sector. Its primary business includes the manufacture and sale of pharmaceutical products. The company functions through three divisions; pharmaceuticals, medical devices, and cosmetics. The pharmaceutical division represents the production of ethical drugs like the local anesthetic. The medical devices division is engaged in developing devices to aid safe preparation of platelet-poor plasma and platelet concentrate from the sample of blood. The company's suite of cosmetic products comprises of cleansers, creams, and sunscreens.

Huons Global Co (XKRX:084110) Headlines

No Headlines